Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
about
Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target AntigenActivity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivoEffect of Fu-Zheng-Xiao-Liu Granules on Expression of Human Epidermal Growth Factor Receptor 2 (HER-2) and Proliferation and Apoptosis of Breast Cancer Cell Line SKBR-3.IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM).Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilarEndophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapyFcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer.Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment.Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting.
P2860
Q36056627-3F212FA0-DE96-4299-9DD1-0C50AAAEABF0Q37072087-2CFEB4DF-7BB4-4530-BAEA-43C95C9A8270Q37551185-914929E3-6C43-47A9-85B2-6FAC2357F852Q37709365-2DF685BD-4DDD-43A0-9AC3-8B4AE8BC1F9BQ38906179-6285E0A1-3688-4F3F-9998-C2396105FE0CQ42281218-E66CC382-0E03-4367-99E6-75D1A89D7A24Q42505702-2E6F9486-96BC-4F89-9A8E-5DA99B1CC44EQ42965942-03386478-3CA4-4CC7-9AA9-33146AFF5AD4Q43072159-A477070E-196E-48EE-8929-48AA0B6109D3Q52599656-B0801C58-CA73-4189-AC13-D0225F7DDACAQ55332501-0E569ADC-DBE9-45D4-820B-120B6369AEFA
P2860
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@ast
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@en
type
label
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@ast
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@en
prefLabel
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@ast
Analysis of in vitro ADCC and ...... s on breast cancer cell lines.
@en
P2093
P2860
P50
P1476
Analysis of in vitro ADCC and ...... ls on breast cancer cell lines
@en
P2093
Alessia D'Alonzo
Anna Morabito
Barbara Cardinali
Beatrice Dozin
Francesca Poggio
Gianluigi Lunardi
Massimo Romani
Roberta Carosio
Sandra Salvi
Silvia Boero
P2860
P2888
P356
10.1186/S12967-015-0680-0
P577
2015-10-08T00:00:00Z
P5875
P6179
1019265141